Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the release of its second annual ESG report, outlining the Company’s long-term commitment to the betterment of society, focusing on patients, our employees, the community, the environment, and shareholders. The report builds on Arena’s inaugural report and highlights specific data and examples of the Company’s work to advance ESG priorities.

“At Arena we believe in operating responsibly by aligning our business priorities with our corporate aspiration to Care More. Act Differently,” said Amit Munshi, Director, President and CEO of Arena Pharmaceuticals. “Our focus on ESG is a journey of continuous improvement as we assess our approach, monitor our impact and build toward the future, incorporating this pattern of thinking into every decision that we make as a company. This ESG focus allows us to build a sustainable company, even in the face of huge challenges such as the COVID pandemic.”

In line with Arena’s focus, this year’s report outlines our evolving approach to managing environmental, social, and governance risks and capturing associated opportunities.

• Arena has aligned its activities with the United Nations Sustainable Development Goals including Good Health and Well-Being; Decent Work and Economic Growth; Industry, Innovation, and Infrastructure; Gender Equality; Reduced Inequalities; Sustainable Cities; and Climate Action.
• We actively seek to inspire and cultivate a vibrant, thriving, and resilient culture that engenders a sense of purpose, community, connection, and gratitude. For 2021, we added a specific corporate objective related to diversity, equity, and inclusion (DEI) initiatives. Arena has created IDE@A (Inclusion, Diversity, and Equity at Arena), an employee group focused on meaningful diversity and inclusion practices for recruiting and employee engagement. This Diversity & Inclusion (D&I) initiative also prioritizes D&I in clinical trials, by striving to reach diverse and representative participant populations for Arena’s ongoing and future studies.
• Arena is committed to using safer, smarter, and sustainable business practices. We look for innovative methods to improve patient and study-participant health, operate responsibly for our stakeholders, and place safety and quality above all else.
• Arena is promoting environmental sustainability within our operations, where our mindset is ‘think globally, act locally.’ We recognize the environmental risks associated with our operations both locally and globally and are in the process of implementing environmental management programs to mitigate such risks in the key areas of energy, water, waste, and pharmaceuticals in the environment.

View the full 2021 Arena ESG Report on the Arena Investor page: https://invest.arenapharm.com/.

About Arena Pharmaceuticals

ARENA Pharmaceuticals is a team with a singular purpose – deliver important medicines to patients.

In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our